Stereotaxis, Inc. (NYSEAMERICAN:STXS) Director Buys $42,171.19 in Stock

Stereotaxis, Inc. (NYSEAMERICAN:STXS) Director Paul J. Isaac purchased 23,299 shares of the business’s stock in a transaction dated Thursday, March 6th. The shares were purchased at an average price of $1.81 per share, with a total value of $42,171.19. Following the purchase, the director now directly owns 49,066 shares in the company, valued at $88,809.46. This trade represents a 90.42 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Stereotaxis Stock Down 4.0 %

NYSEAMERICAN STXS traded down $0.08 during trading on Monday, hitting $1.80. 206,459 shares of the company’s stock traded hands, compared to its average volume of 448,136. The stock has a market capitalization of $152.09 million, a PE ratio of -6.41 and a beta of 1.54. Stereotaxis, Inc. has a 12-month low of $1.66 and a 12-month high of $3.29. The business’s 50 day simple moving average is $2.27.

Institutional Investors Weigh In On Stereotaxis

A number of hedge funds and other institutional investors have recently bought and sold shares of STXS. Traynor Capital Management Inc. purchased a new position in Stereotaxis during the fourth quarter valued at approximately $366,000. Charles Schwab Investment Management Inc. grew its position in shares of Stereotaxis by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock valued at $341,000 after purchasing an additional 15,491 shares in the last quarter. State Street Corp increased its holdings in shares of Stereotaxis by 5.7% in the third quarter. State Street Corp now owns 680,612 shares of the company’s stock worth $1,388,000 after purchasing an additional 36,518 shares during the period. Barclays PLC increased its holdings in shares of Stereotaxis by 449.9% in the third quarter. Barclays PLC now owns 101,953 shares of the company’s stock worth $208,000 after purchasing an additional 83,412 shares during the period. Finally, Geode Capital Management LLC raised its position in shares of Stereotaxis by 7.2% in the third quarter. Geode Capital Management LLC now owns 1,391,718 shares of the company’s stock worth $2,840,000 after buying an additional 93,253 shares in the last quarter. Institutional investors own 45.35% of the company’s stock.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.